ATE554083T1 - Verfahren zur herstellung eines säureadditionssalzes einer polyaciden basenverbindung - Google Patents

Verfahren zur herstellung eines säureadditionssalzes einer polyaciden basenverbindung

Info

Publication number
ATE554083T1
ATE554083T1 AT04715495T AT04715495T ATE554083T1 AT E554083 T1 ATE554083 T1 AT E554083T1 AT 04715495 T AT04715495 T AT 04715495T AT 04715495 T AT04715495 T AT 04715495T AT E554083 T1 ATE554083 T1 AT E554083T1
Authority
AT
Austria
Prior art keywords
addition salt
acid addition
producing
base compound
basic compound
Prior art date
Application number
AT04715495T
Other languages
English (en)
Inventor
Kimiyuki Shibuya
Tadaaki Ohgiya
Takayuki Matsuda
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Application granted granted Critical
Publication of ATE554083T1 publication Critical patent/ATE554083T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
AT04715495T 2003-02-28 2004-02-27 Verfahren zur herstellung eines säureadditionssalzes einer polyaciden basenverbindung ATE554083T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003052700 2003-02-28
PCT/JP2004/002375 WO2004076441A1 (ja) 2003-02-28 2004-02-27 多酸性塩基化合物の酸付加塩の製造方法

Publications (1)

Publication Number Publication Date
ATE554083T1 true ATE554083T1 (de) 2012-05-15

Family

ID=32923406

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04715495T ATE554083T1 (de) 2003-02-28 2004-02-27 Verfahren zur herstellung eines säureadditionssalzes einer polyaciden basenverbindung

Country Status (21)

Country Link
US (2) US7750150B2 (de)
EP (1) EP1598346B1 (de)
JP (2) JP4594863B2 (de)
KR (1) KR101106127B1 (de)
CN (2) CN1753886B (de)
AT (1) ATE554083T1 (de)
AU (1) AU2004215523B2 (de)
BR (1) BRPI0407908A (de)
CA (1) CA2516822C (de)
DK (1) DK1598346T3 (de)
EA (1) EA009045B1 (de)
ES (1) ES2384517T3 (de)
IL (1) IL170093A (de)
IS (1) IS7978A (de)
MX (1) MXPA05009129A (de)
MY (1) MY140618A (de)
NO (1) NO331272B1 (de)
NZ (1) NZ541716A (de)
PL (1) PL378292A1 (de)
TW (2) TWI374136B (de)
WO (1) WO2004076441A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI324600B (en) * 2003-07-07 2010-05-11 Kowa Co 2,4-bis (trifluoroethoxy) pyridine compound and drug containing the compound
KR20060111898A (ko) 2003-08-29 2006-10-30 교와 가부시키가이샤 지질-풍부-플라크의 안정화 방법 및 파열 예방방법
TW200619204A (en) * 2004-12-10 2006-06-16 Kowa Co Method for reduction, stabilization and prevention of rupture of lipid rich plaque
AU2006285915B2 (en) 2005-08-30 2011-02-24 Asahi Kasei Pharma Corporation Sulfonamide compound
US8415372B2 (en) * 2007-02-27 2013-04-09 Asahi Kasei Pharma Corporation Sulfonamide compound
CA2679263A1 (en) 2007-02-28 2008-09-04 Asahi Kasei Pharma Corporation Sulfonamide compound
WO2009004792A1 (ja) * 2007-07-02 2009-01-08 Asahi Kasei Pharma Corporation スルホンアミド化合物及びその結晶
US9273209B2 (en) * 2007-11-30 2016-03-01 Braggone Oy Siloxane polymer compositions
CN102711762A (zh) * 2009-12-29 2012-10-03 兴和株式会社 口服用固体医药组合物
WO2011081118A1 (ja) * 2009-12-29 2011-07-07 興和株式会社 経口投与用医薬組成物
US20130066075A1 (en) * 2010-05-19 2013-03-14 Kowa Company, Ltd. Prophylactic and/or therapeutic agent for non-alcoholic steatohepatitis
WO2016205141A1 (en) * 2015-06-17 2016-12-22 Gilead Sciences, Inc. Co-crystals, salts and solid forms of tenofovir alafenamide
JPWO2018092765A1 (ja) * 2016-11-15 2019-10-17 学校法人同志社 経鼻投与用医薬組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL112152A (en) * 1994-12-26 2000-11-21 Identa Ltd Process and test kit for cocaine detection
US6969711B2 (en) * 1997-05-26 2005-11-29 Kowa Company, Ltd. Cyclic diamine compounds and medicine containing the same
HUP0002294A3 (en) * 1997-05-26 2001-10-29 Kowa Co Cyclic diamine compounds and medicines containing the same
GB9826180D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
US20060165605A1 (en) * 2001-12-28 2006-07-27 Ye-Mon Chen Process to regenerate fcc spent catalyst
EP1571144A4 (de) * 2002-12-12 2007-08-01 Kowa Co Hydroxyalkylierte cyclischediaminverbindung
TWI324600B (en) * 2003-07-07 2010-05-11 Kowa Co 2,4-bis (trifluoroethoxy) pyridine compound and drug containing the compound

Also Published As

Publication number Publication date
TWI374136B (en) 2012-10-11
CN1753886B (zh) 2012-07-18
WO2004076441A1 (ja) 2004-09-10
US20060079688A1 (en) 2006-04-13
JP4594863B2 (ja) 2010-12-08
BRPI0407908A (pt) 2006-02-14
MXPA05009129A (es) 2005-10-20
NO20054100L (no) 2005-09-22
MY140618A (en) 2009-12-31
US8518936B2 (en) 2013-08-27
CN102702171B (zh) 2014-09-10
DK1598346T3 (da) 2012-05-29
AU2004215523A1 (en) 2004-09-10
TW201202218A (en) 2012-01-16
PL378292A1 (pl) 2006-03-20
CA2516822A1 (en) 2004-09-10
ES2384517T3 (es) 2012-07-06
KR101106127B1 (ko) 2012-01-20
CN102702171A (zh) 2012-10-03
AU2004215523B2 (en) 2009-07-16
TW200504052A (en) 2005-02-01
EP1598346A4 (de) 2007-08-15
EP1598346B1 (de) 2012-04-18
TWI355384B (en) 2012-01-01
NZ541716A (en) 2007-11-30
US20100234599A1 (en) 2010-09-16
JPWO2004076441A1 (ja) 2006-06-01
CA2516822C (en) 2012-09-25
NO331272B1 (no) 2011-11-14
JP5180998B2 (ja) 2013-04-10
US7750150B2 (en) 2010-07-06
IS7978A (is) 2005-08-12
CN1753886A (zh) 2006-03-29
EA009045B1 (ru) 2007-10-26
EP1598346A1 (de) 2005-11-23
EA200501379A1 (ru) 2006-02-24
IL170093A (en) 2012-02-29
NO20054100D0 (no) 2005-09-02
KR20050105218A (ko) 2005-11-03
JP2010235635A (ja) 2010-10-21

Similar Documents

Publication Publication Date Title
ATE451380T1 (de) Verfahren zur herstellung von bisphosphonsäureverbindungen
ATE506356T1 (de) Verfahren zur herstellung von 3-halo-4,5-dihydro- 1h-pyrazolen
DE60035577D1 (de) Verfahren zur herstellung von fluorverbindungen mittels flüssigphasenfluorierung
ATE371657T1 (de) Verfahren zur herstellung kondensierter oxazinone aus einer aromatischen ortho-aminocarbonsäure und einer carbonsäure in gegenwart eines sulfonylchlorids und pyridin
NO20054100L (no) Fremgangsmate for fremstilling av syreaddisjonssalter
DE60208459D1 (de) Verfahren zur Herstellung einer Zielsubstanz mittels Fermentation
ATE506352T1 (de) Verfahren zur herstellung von optional 2- substituierten 1,6-dihydro-6-oxo-4- pyrimidincarboxylsäuren
ATE332189T1 (de) Verfahren zur herstellung von carbonsäuresalzen
ATE305919T1 (de) Verfahren zur herstellung von salzen der methallylsulfonsäure
ATE310735T1 (de) Verfahren zur herstellung von spirocyclischen tetronsäurederivaten
DE60207623D1 (de) Verfahren zur Verbesserung der Viskositätsstabilität durch Zusatz einer wässrigen Färbungszusammensetzung
DE60234279D1 (de) Verfahren zur herstellung eines immunosuppresivums
DE602007005077D1 (de) Verfahren zur Herstellung von Pyridinmethylsulphinylverbindungen
ATE469141T1 (de) Verfahren zur herstellung von substituierten thiophensulfonylisocyanaten
DE602006015458D1 (de) Verfahren zur herstellung eines carbonsäureamidderivats
DE602005026841D1 (de) Verfahren zur herstellung von 1,2,2,2-tetrafluor-ethyl-difluor-methylether
ATE425972T1 (de) Verfahren zur herstellung substituierter imidazolderivate und in dem verfahren verwendete zwischenprodukte
ATE381532T1 (de) Verfahren zur herstellung von gabapentin
DE502005007096D1 (de) Verfahren zur herstellung von alkenen durch eliminierung von wasser aus alkoholen mit alkylphosphonsäureanhydriden
DE50304869D1 (de) Verfahren zur herstellung einer spezifischen kristallmodifikation von 2-(2-chlor-4-mesyl-benzoyl)-cyclohexan-1,3-dion
ATE330946T1 (de) Verfahren zur herstellung einer benzylamin- verbindung
DE602006005488D1 (de) Verfahren zur herstellung von losartanderivaten durch chlorierung und reduktion der entsprechenden 1h-imidazol-5-carbaldehyde
ATE366719T1 (de) Verfahren zur herstellung von 2,6- dichlorphenolverbindungen
TW200700370A (en) Producing method of haloalkylether compounds
ATE556063T1 (de) Verfahren zur herstellung einer epoxyverbindung